Advertisement
Screener

AKEBIA THERAPEUTICS, INC. (AKBA) Contractual Obligation, to be Paid, Year Four

2.8 / 5 stars · 68/120 Roast Me

AKEBIA THERAPEUTICS, INC. Contractual Obligation, to be Paid, Year Four

AKEBIA THERAPEUTICS, INC. (AKBA) had Contractual Obligation, to be Paid, Year Four of $3.54 million as of 2017-09-30, per its 10-Q filed 2017-11-08.

Discontinued › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity › Contractual Obligation, to be Paid, Year Four and Five

us-gaap:ContractualObligationDueInFourthYear · last filed 2017-11-08

  • 2017-09-30: Contractual Obligation, to be Paid, Year Four $3.54M.
  • 2017-06-30: Contractual Obligation, to be Paid, Year Four $3.54M.
  • 2017-03-31: Contractual Obligation, to be Paid, Year Four $3.54M.
  • 2016-12-31: Contractual Obligation, to be Paid, Year Four $3.54M.
Period endContractual Obligation, to be Paid, Year Four
2017-09-30$3.54M
10-Q · filed 2017-11-08
2017-06-30$3.54M
10-Q · filed 2017-08-08
2017-03-31$3.54M
10-Q · filed 2017-05-09
2016-12-31$3.54M
10-K · filed 2017-03-06
2016-09-30$3.12M
10-Q · filed 2016-11-09
2016-06-30$3.12M
10-Q · filed 2016-08-08
2016-03-31$3.12M
10-Q · filed 2016-05-05
2015-12-31$3.12M
10-K · filed 2016-03-14
2015-09-30$1.00K
10-Q · filed 2015-11-09
2015-06-30$1.00K
10-Q · filed 2015-08-11
2015-03-31$1.00K
10-Q · filed 2015-05-11
2014-06-30$350.00
10-Q · filed 2014-08-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
MACROGENICS INC (MGNX)United States$0.242B-20.11
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33